EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Veracyte, Inc. (VCYT) had EBITDA Margin of 14.68% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$517.14M |
|
$66.35M |
|
$154.61M |
|
$362.53M |
|
$459.37M |
|
$57.78M |
|
$10.42M |
|
$68.20M |
|
$68.20M |
|
$66.35M |
|
$66.35M |
|
$66.35M |
|
$66.35M |
|
$57.78M |
|
$75.92M |
|
78.58M |
|
80.57M |
|
$0.84 |
|
$0.82 |
|
| Balance Sheet Financials | |
$488.38M |
|
$22.19M |
|
$917.64M |
|
$1.41B |
|
$59.94M |
|
-- |
|
$36.51M |
|
$96.44M |
|
$1.31B |
|
$453.27M |
|
$1.31B |
|
79.36M |
|
| Cash Flow Statement Financials | |
$136.31M |
|
$-9.21M |
|
$-4.22M |
|
$240.63M |
|
$364.23M |
|
$123.59M |
|
$43.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
70.10% |
|
11.17% |
|
11.17% |
|
|
EBITDA Margin |
14.68% |
13.19% |
|
12.83% |
|
$126.63M |
|
-- |
|
-- |
|
-- |
|
0.37 |
|
7.53 |
|
11.58 |
|
31.52 |
|
5.07% |
|
14.64% |
|
4.72% |
|
5.07% |
|
$16.50 |
|
$1.57 |
|
$1.69 |
|